We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+8.53%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$94B
AUM Growth
+$5.35B
Cap. Flow
-$10.2B
Cap. Flow %
-10.87%
Top 10 Hldgs %
22.25%
Holding
2,551
New
400
Increased
743
Reduced
692
Closed
262

Sector Composition

Rank Sector Weight
1 Technology 20.36%
2 Healthcare 14.2%
3 Financials 13.3%
4 Industrials 9.5%
5 Consumer Discretionary 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPOP icon
1451
Popular Inc
BPOP
$11.1B
$60K ﹤0.01%
738
+364
+97% +$29.5K
CACI icon
1452
CACI
CACI
$14.2B
$60K ﹤0.01%
223
-14,014
-98% -$3.84M
DOCN icon
1453
DigitalOcean
DOCN
$14.6B
$60K ﹤0.01%
+756
New +$70.8K
GEF icon
1454
Greif
GEF
$5.04B
$60K ﹤0.01%
1,006
+419
+71% +$27.1K
LII icon
1455
Lennox International
LII
$15.2B
$60K ﹤0.01%
185
-189
-51% -$59.1K
RNAC icon
1456
Cartesian Therapeutics
RNAC
$268M
$60K ﹤0.01%
619
+197
+47% +$21.2K
TIPT icon
1457
Tiptree Inc
TIPT
$675M
$60K ﹤0.01%
4,389
HCCI
1458
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$60K ﹤0.01%
1,896
+88
+5% +$2.86K
CCXI
1459
DELISTED
ChemoCentryx, Inc.
CCXI
$60K ﹤0.01%
+1,653
New +$58K
CUBE icon
1460
CubeSmart
CUBE
$9.41B
$59K ﹤0.01%
1,051
+64
+6% +$3.44K
G icon
1461
Genpact
G
$5.81B
$59K ﹤0.01%
1,130
-26,045
-96% -$1.31M
ONB icon
1462
Old National Bancorp
ONB
$10.2B
$59K ﹤0.01%
3,308
-598
-15% -$10.6K
SUPN icon
1463
Supernus Pharmaceuticals
SUPN
$2.77B
$59K ﹤0.01%
2,024
+274
+16% +$8.31K
THRY icon
1464
Thryv Holdings
THRY
$108M
$59K ﹤0.01%
+1,453
New +$50K
MYOV
1465
DELISTED
Myovant Sciences Ltd.
MYOV
$59K ﹤0.01%
3,803
+3,230
+564% +$61.7K
ATRS
1466
DELISTED
Antares Pharma, Inc.
ATRS
$59K ﹤0.01%
16,736
+9,580
+134% +$33.5K
CMRE icon
1467
Costamare
CMRE
$1.77B
$58K ﹤0.01%
4,640
+2,237
+93% +$29.3K
HONE
1468
DELISTED
HarborOne Bancorp
HONE
$58K ﹤0.01%
3,970
TLRY icon
1469
Tilray
TLRY
$622M
$58K ﹤0.01%
838
VNDA icon
1470
Vanda Pharmaceuticals
VNDA
$302M
$58K ﹤0.01%
3,700
+481
+15% +$8.38K
VSEC icon
1471
VSE Corp
VSEC
$6.12B
$58K ﹤0.01%
+954
New +$53.3K
WD icon
1472
Walker & Dunlop
WD
$1.53B
$58K ﹤0.01%
386
+142
+58% +$19.8K
WOW
1473
DELISTED
WideOpenWest
WOW
$58K ﹤0.01%
+2,735
New +$54.5K
XNCR icon
1474
Xencor
XNCR
$1.55B
$58K ﹤0.01%
1,480
-24,268
-94% -$920K
HRT
1475
DELISTED
HireRight Holdings Corporation
HRT
$58K ﹤0.01%
+3,635
New +$60.8K

Similar funds

Lazard Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Lazard Asset Management held 2,551 positions worth $94B, up 6% from $88.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Lazard Asset Management withdrew a net $10.2B in Q4 2021, closing 262 positions and reducing 692 holdings. Its most notable exit was Innospec, an estimated $21M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lazard Asset Management opened a new position in Wells Fargo 7.5% Non Cumv Perp Conv worth $922K.

  • Lazard Asset Management's largest Q4 2021 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 61,920 shares worth $922K.
  • Lazard Asset Management added most to Pinnacle West Capital in Q4 2021, an estimated $455M increase.
  • Lazard Asset Management's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $545M.
  • Lazard Asset Management fully exited Innospec in Q4 2021, selling an estimated $21M.
  • Lazard Asset Management's ten largest holdings make up 22% of its $94B portfolio in Q4 2021.
  • Lazard Asset Management opened 400 new positions and closed 262 in Q4 2021.
  • Lazard Asset Management's portfolio value rose 6% quarter-over-quarter to $94B.

Based on Lazard Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.